1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MERCK & CO INC
Merck & Co Inc
XNYS: MRK
Momentum Trap
Download real time
148.69 -0.09 (-0.06%)
90.55% Gain from 52W Low
7.6M
XNYS Volume

XNYS 28 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
FDA Approval
Merck receives FDA nod for Welireg/Lenvima combo to treat kidney cancer, targeting a $14 bn market See details

Merck & Company - MRK - stock price prediction, stock price target, analyst ratings from 28 analysts

Merck & Company has a share price target of US$ 154, revenue growth forecast of 3.3%, and profit growth estimate of -82.1% for FY26, based on top 28 analyst calls.

Forecaster Screeners